Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...

Absci (NASDAQ:ABSI) was rising after a media report about the semiconductor company Advanced Micro Devices (NASDAQ:AMD) ...

HSBC analyst Frank Lee sees that trend continuing, and lowered his price target on AMD shares by $90, to $110 per share, and ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Among Nvidia, Apple, Microsoft, Amazon, Alphabet, Meta Platforms, and Tesla, there's a phenomenal bargain hiding in plain ...

Dell Technologies (NYSE: DELL) builds on decades of PC innovation with a new, simplified portfolio featuring on-device AI for ...

iShares U.S. Technology ETF IYW -2.29% + Free Alerts has $20.5 billion funds under management and charges an expense ratio of ...

Dell’s embrace of AMD for corporate PCs — it already uses the chipmaker for consumer devices — is another blow for Intel Corp ...

Detailed price information for Adv Micro Devices (AMD-Q) from The Globe and Mail including charting and trades.

All part of the brand’s desire to “transform screens into adaptive, intelligent companions that simplify and enrich every day ...